CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/12/2021
Voltar para busca
Dado oficial do USPTO
UNITHER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
56
Atualização mais recente
07/04/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42
Data de depósito
07/12/2007
Data de registro
02/06/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/12/2015
Última transação
07/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
F-80084 AMIENS CEDEX 2, FR
Examinador
FRAZIER,TAMARA G
Unidade examinadora
M70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
U. P. (pessoa física)
U. D. (pessoa física)
Representantes
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsappetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical sedative preparations; Pharmaceutical preparations for use in urology; Yeast or yeast extracts for medical or pharmaceutical purposes; Pharmaceutical products for ophthalmologic use; Pharmaceutical preparations for wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for human skincare; Anti-diabetic pharmaceuticals; Pharmaceutical antiseptic preparations; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsa drug delivery system comprising oral alcoholic liquid for per lingual release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Unit dose capsules sold empty for pharmaceutical use
Classe 10
Aerosol dispensers for medical use; Dropper bottles for administering medicationsold empty; Droppers for administering medicationsold empty; Drug delivery systems; Use dose bottles and capsules for per lingual delivering medication
Classe 42
Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Research and development of pharmaceutical capsules for pharmaceutical use * Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Research and development of pharmaceutical capsules for pharmaceutical use; all of the foregoing for use in connection with custom manufacturing of pharmaceuticals or packaging for third parties *
Publicações
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/12/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
16/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/12/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
05/07/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/07/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/07/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/05/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
28/05/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/06/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
22/12/2015
CANT
CANCELLATION TERMINATED NO. 999999
22/12/2015
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
20/11/2015
PLGL
ASSIGNED TO PARALEGAL
20/11/2015
CAND
CANCELLATION DENIED NO. 999999
20/11/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/10/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/10/2015
CORV
REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
03/08/2015
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
30/07/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
28/05/2015
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
28/05/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/05/2015
ES8R
TEAS SECTION 8 RECEIVED
18/05/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
19/11/2014
PETC
CANCELLATION INSTITUTED NO. 999999
02/06/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/01/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/01/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2009
PUBO
PUBLISHED FOR OPPOSITION
17/03/2009
NPUB
NOTICE OF PUBLICATION
25/02/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/02/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/02/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
27/01/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
22/01/2009
CNSL
LETTER OF SUSPENSION MAILED
22/07/2008
CNSL
SUSPENSION LETTER WRITTEN
21/07/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2008
CNRT
NON-FINAL ACTION MAILED
19/03/2008
CNRT
NON-FINAL ACTION WRITTEN
19/03/2008
DOCK
ASSIGNED TO EXAMINER
17/03/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/03/2008
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/03/2008
ALIE
ASSIGNED TO LIE
06/03/2008
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/02/2008
NWAP
NEW APPLICATION ENTERED
12/12/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UNITHER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.